secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azitra, Inc. (AZTR)
CIK:        0001701478
Form:       8-K
Filed at:   2026-09-08T12:05:29+00:00
Accession:  0001493152-26-041706
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azitra to present at H.C. Wainwright conference; update on ATR-COSF and ATR-04
------------------------------------------------------------------------------

- COO Travis Whitfill to present virtually at H.C. Wainwright 28th Annual Global Investment Conference, Sept 14-16, 2026.
- Presentation will include initial data from ATR-COSF program for cosmetic applications targeting fine lines and wrinkles.
- Will discuss continued enrollment in first cohort of Phase 1/2 trial of ATR-04 for EGFR inhibitor-associated rash.
- ATR-04 has FDA Fast Track designation; EGFRi rash impacts ~150,000 people in U.S.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701478/000149315226041706/0001493152-26-041706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701478/000149315226041706/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer